You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory and solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Precision Medicine Treatment for Refractory Solid Tumors

Recruiting
  • Refractory Solid Tumors
  • Next Generation Sequencing
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Sep 2, 2023

    Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

    Recruiting
    • Refractory Solid Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2023

    Cancer Trial (Antibody-Drug Conjugate)

    Not yet recruiting
    • Cancer
    • Antibody-Drug Conjugate
    • (no location specified)
    Aug 23, 2023

    Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)

    Withdrawn
    • Relapsed Solid Neoplasm
    • +2 more
    • STI-3258
    • (no location specified)
    Jan 24, 2023

    Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)

    Recruiting
    • Colon Cancer
    • Chimeric antigen receptor T cell preparation targeting GCC
    • Qingdao, Shandong, China
      The Affiliated Hospital of Qingdao University
    May 16, 2023

    Solid Tumor, Adult, Refractory Tumor Trial in Dallas, San Antonio (DCR-STAT3)

    Recruiting
    • Solid Tumor, Adult
    • Refractory Tumor
    • Dallas, Texas
    • +1 more
    Oct 21, 2023

    Solid Tumor Trial in Taichung (HLA-G-CAR.BiTE allogeneic ?d T cells)

    Not yet recruiting
    • Solid Tumor
    • HLA-G-CAR.BiTE allogeneic γδ T cells
    • Taichung, Non-US, Taiwan
      China Medical University Hospital
    Nov 27, 2023

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Mar 29, 2023

    Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

    Completed
    • Advanced Refractory Solid Tumors
    • T-1101 (Tosylate)
    • Taichung City, Taiwan
    • +3 more
    Nov 17, 2022

    Cancer, Cancer of Pancreas, Sarcoma Trial (STI-1386)

    Not yet recruiting
    • Cancer
    • +4 more
    • (no location specified)
    Dec 15, 2022

    TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSX01-TCRT injection)

    Recruiting
    • TCR-T Cells
    • +2 more
    • KSX01-TCRT injection
    • Nanning, Guangxi Zhuang Autonomous Region, China
      The first affiliated hospital of Guang Xi medical university
    Mar 31, 2023

    Refractory Solid Tumors Trial in Seoul (pazopanib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

    Recruiting
    • Refractory Solid Tumors
    • Relapsed Solid Tumors
    • KSX01-TCRT cell therapy
    • Beijing, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Nov 21, 2023

    Refractory Solid Tumors Trial in Seoul (sirolimus)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors Trial in Seoul (Sunitinib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

    Not yet recruiting
    • Solid Tumor
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    Aug 30, 2022

    Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +4 more
    • CTX131
    • Nashville, Tennessee
      Research Site 1
    Mar 21, 2023

    Refractory Malignant Solid Tumor Trial (PCNA Inhibitor AOH1996)

    Recruiting
    • Refractory Malignant Solid Neoplasm
    • PCNA Inhibitor AOH1996
    • Scottsdale, Arizona
    • +1 more
    Sep 29, 2022

    TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

    Recruiting
    • TCR-T Cells
    • +2 more
    • KSH01 injection
    • Nanning, Guang XI, China
      The first affiliated hospital of Guang Xi medical university
    Sep 14, 2022

    DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors

    Recruiting
    • Solid Tumor
    • Individuation
    • Recommended treatment plan
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Aug 23, 2023

    Refractory Solid Tumors Trial in Seoul (pazopanib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors Trial in Seoul (sunitinib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)

    Active, not recruiting
    • Solid Neoplasm
    • Laboratory Biomarker Analysis
    • +2 more
    • Jacksonville, Florida
    • +1 more
    Jan 25, 2023

    Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

    Recruiting
    • Ewing Sarcoma
    • +5 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

    Not yet recruiting
    • Sarcoma, Ewing
    • Rhabdomyosarcoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022